135 related articles for article (PubMed ID: 10726889)
1. Species differences in oral bioavailability of methotrexate between rats and monkeys.
Kuroda T; Namba K; Torimaru T; Kawashima K; Hayashi M
Biol Pharm Bull; 2000 Mar; 23(3):334-8. PubMed ID: 10726889
[TBL] [Abstract][Full Text] [Related]
2. Variability of oral bioavailability for low dose methotrexate in rats.
Kuroda T; Namba K; Torimaru T; Yamamoto S; Akahori M
Eur J Drug Metab Pharmacokinet; 2001; 26(4):227-34. PubMed ID: 11808864
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
4. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
Chládková J; Hak J; Martínková J; Chládek J
Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
[TBL] [Abstract][Full Text] [Related]
5. Simple and sensitive HPLC method for the fluorometric determination of methotrexate and its major metabolites in human plasma by post-column photochemical reaction.
Uchiyama M; Matsumoto T; Matsumoto T; Jimi S; Takamatsu Y; Tamura K; Hara S
Biomed Chromatogr; 2012 Jan; 26(1):76-80. PubMed ID: 21437923
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.
Widemann BC; Sung E; Anderson L; Salzer WL; Balis FM; Monitjo KS; McCully C; Hawkins M; Adamson PC
J Pharmacol Exp Ther; 2000 Sep; 294(3):894-901. PubMed ID: 10945838
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
8. In vivo-in vitro relationship of methotrexate 7-hydroxylation by aldehyde oxidase in four different strain rats.
Moriyasu A; Sugihara K; Nakatani K; Ohta S; Kitamura S
Drug Metab Pharmacokinet; 2006 Dec; 21(6):485-91. PubMed ID: 17220564
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
10. Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo.
Vlaming ML; van Esch A; Pala Z; Wagenaar E; van de Wetering K; van Tellingen O; Schinkel AH
Mol Cancer Ther; 2009 Dec; 8(12):3350-9. PubMed ID: 19996279
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of methotrexate and its eight metabolites in human whole blood by capillary zone electrophoresis.
Kuo CY; Wu HL; Kou HS; Chiou SS; Wu DC; Wu SM
J Chromatogr A; 2003 Oct; 1014(1-2):93-101. PubMed ID: 14558615
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) in rats and evidence for the metabolism of MTX to 7-OH-MTX.
Fahrig L; Brasch H; Iven H
Cancer Chemother Pharmacol; 1989; 23(3):156-60. PubMed ID: 2924373
[TBL] [Abstract][Full Text] [Related]
13. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
14. Impact of abcc2 [multidrug resistance-associated protein (MRP) 2], abcc3 (MRP3), and abcg2 (breast cancer resistance protein) on the oral pharmacokinetics of methotrexate and its main metabolite 7-hydroxymethotrexate.
Vlaming ML; van Esch A; van de Steeg E; Pala Z; Wagenaar E; van Tellingen O; Schinkel AH
Drug Metab Dispos; 2011 Aug; 39(8):1338-44. PubMed ID: 21566011
[TBL] [Abstract][Full Text] [Related]
15. What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?
Chan BS; Dawson AH; Buckley NA
Clin Toxicol (Phila); 2017 Feb; 55(2):88-96. PubMed ID: 28084171
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats.
Masuda M; I'izuka Y; Yamazaki M; Nishigaki R; Kato Y; Ni'inuma K; Suzuki H; Sugiyama Y
Cancer Res; 1997 Aug; 57(16):3506-10. PubMed ID: 9270020
[TBL] [Abstract][Full Text] [Related]
17. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
Fox RI; Morgan SL; Smith HT; Robbins BA; Choc MG; Baggott JE
Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
[TBL] [Abstract][Full Text] [Related]
18. Carboxypeptidase G2 rescue after high-dose methotrexate.
DeAngelis LM; Tong WP; Lin S; Fleisher M; Bertino JR
J Clin Oncol; 1996 Jul; 14(7):2145-9. PubMed ID: 8683248
[TBL] [Abstract][Full Text] [Related]
19. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo.
Bremnes RM; Slørdal L; Wist E; Aarbakke J
Cancer Res; 1989 Nov; 49(22):6359-64. PubMed ID: 2804982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]